Modulation of prostaglandin metabolism by K-MAP and prevention of toxic effect of cyclosporin on pancreatic islet cells

Diabetes. 1989 Jan:38 Suppl 1:120-5. doi: 10.2337/diab.38.1.s120.

Abstract

The injection of 25 mg/kg i.p. cyclosporin (CsA) for 3 wk caused marked functional and morphological deteriorations of pancreatic islet cells in Wistar rats that were prevented by the combined administration of p-aminobenzoic acid-N-D-mannoside sodium salt (K-MAP). In this article, the toxic effect of CsA on pancreatic islet cells and the preventive effect of K-MAP on CsA-associated islet cell toxicity were investigated. Prolonged hyperglycemia and depressed insulin secretion after the glucose challenge observed in CsA-treated rats could be prevented by the combined administration of 300 and 900 mg/kg K-MAP. Cytoplasmic vacuolizations and a decrease in the number of mitochondria, intact endoplasmic reticula, secretory granules, and insulin-positive cells, as revealed by peroxidase-antiperoxidase staining, could also be prevented by the administration of 900 mg/kg K-MAP. This preventive effect of K-MAP on CsA-associated islet cell toxicity may suggest the combined use of K-MAP with CsA in pancreas transplantation and treatment of insulin-dependent diabetes.

MeSH terms

  • 4-Aminobenzoic Acid / pharmacology*
  • Aminobenzoates / pharmacology*
  • Animals
  • Cyclosporins / toxicity*
  • Drug Interactions
  • Islets of Langerhans / drug effects
  • Islets of Langerhans / metabolism*
  • Male
  • Mannose / analogs & derivatives*
  • Mannose / pharmacology
  • Microcirculation / drug effects
  • Prostaglandins / metabolism*
  • Rats
  • Rats, Inbred Strains
  • Thromboxane B2 / urine
  • Weight Gain / drug effects
  • para-Aminobenzoates

Substances

  • Aminobenzoates
  • Cyclosporins
  • Prostaglandins
  • para-Aminobenzoates
  • Thromboxane B2
  • 4-aminobenzoic acid-N-mannoside
  • Mannose
  • 4-Aminobenzoic Acid